[go: up one dir, main page]

MX2010003591A - Capa protectora mecanica para formas de dosificacion solidas. - Google Patents

Capa protectora mecanica para formas de dosificacion solidas.

Info

Publication number
MX2010003591A
MX2010003591A MX2010003591A MX2010003591A MX2010003591A MX 2010003591 A MX2010003591 A MX 2010003591A MX 2010003591 A MX2010003591 A MX 2010003591A MX 2010003591 A MX2010003591 A MX 2010003591A MX 2010003591 A MX2010003591 A MX 2010003591A
Authority
MX
Mexico
Prior art keywords
protective layer
solid dosage
dosage forms
mechanical protective
same
Prior art date
Application number
MX2010003591A
Other languages
English (en)
Inventor
Luis Soler Ranzani
Gemma Casadevall Pujals
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MX2010003591A publication Critical patent/MX2010003591A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Optical Filters (AREA)

Abstract

La presente invenci?n se refiere a una capa protectora mec?nica para pellets que comprende al menos dos agentes plastificantes, a un m?todo para preparar la misma y a una forma de dosificaci?n s?lida que comprende la misma.
MX2010003591A 2007-10-04 2008-10-03 Capa protectora mecanica para formas de dosificacion solidas. MX2010003591A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380270A EP2044932A1 (en) 2007-10-04 2007-10-04 Mechanical protective layer for solid dosage forms
PCT/EP2008/063279 WO2009043929A1 (en) 2007-10-04 2008-10-03 Mechanical protective layer for solid dosage forms

Publications (1)

Publication Number Publication Date
MX2010003591A true MX2010003591A (es) 2010-04-21

Family

ID=39154060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003591A MX2010003591A (es) 2007-10-04 2008-10-03 Capa protectora mecanica para formas de dosificacion solidas.

Country Status (15)

Country Link
US (1) US20100247641A1 (es)
EP (2) EP2044932A1 (es)
JP (1) JP5442620B2 (es)
KR (1) KR20100091956A (es)
CN (1) CN101820866B (es)
AU (1) AU2008306846B2 (es)
BR (1) BRPI0817863A2 (es)
CA (1) CA2701556A1 (es)
ES (1) ES2507079T3 (es)
IL (1) IL204815A0 (es)
MX (1) MX2010003591A (es)
NZ (1) NZ584453A (es)
RU (1) RU2500389C2 (es)
WO (1) WO2009043929A1 (es)
ZA (1) ZA201002257B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
EP2468263A1 (en) * 2010-12-23 2012-06-27 Laboratorios Del. Dr. Esteve, S.A. Compressed solid dosage forms
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7064683B2 (ja) * 2017-01-27 2022-05-11 日本ケミファ株式会社 腸溶層破損防止用組成物
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
CN116270514B (zh) * 2023-03-22 2024-09-06 北京恒创星远医药科技有限公司 一种微丸片剂及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
JPH07106989B2 (ja) * 1988-09-27 1995-11-15 武田薬品工業株式会社 腸溶性被膜
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP3746167B2 (ja) * 1998-05-18 2006-02-15 武田薬品工業株式会社 医薬製剤
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US6565873B1 (en) * 2000-10-25 2003-05-20 Salvona Llc Biodegradable bioadhesive controlled release system of nano-particles for oral care products
US6673373B2 (en) * 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
US6766817B2 (en) * 2001-07-25 2004-07-27 Tubarc Technologies, Llc Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
US20060257482A1 (en) * 2002-06-07 2006-11-16 Patrik Kumar Modified release, multiple unit drug delivery systems
US7285255B2 (en) * 2002-12-10 2007-10-23 Ecolab Inc. Deodorizing and sanitizing employing a wicking device
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
ES2261006B1 (es) 2004-06-10 2007-11-01 Laboratorios Rubio, S.A. Pellet multicapa de liberacion controlada de metilfenidato.
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
BRPI0614545B8 (pt) * 2005-08-15 2021-05-25 Abbott Products Gmbh composição farmacêutica de liberação controlada, seu processo de produção, forma de dosagem oral com revestimento entérico de pacreatina e uso da mesma
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets

Also Published As

Publication number Publication date
CA2701556A1 (en) 2009-04-09
WO2009043929A1 (en) 2009-04-09
IL204815A0 (en) 2010-11-30
JP2010540596A (ja) 2010-12-24
ZA201002257B (en) 2011-06-29
EP2207534A1 (en) 2010-07-21
CN101820866B (zh) 2012-12-05
AU2008306846B2 (en) 2013-09-05
US20100247641A1 (en) 2010-09-30
RU2500389C2 (ru) 2013-12-10
HK1144180A1 (en) 2011-02-02
EP2044932A1 (en) 2009-04-08
RU2010117391A (ru) 2011-11-10
CN101820866A (zh) 2010-09-01
JP5442620B2 (ja) 2014-03-12
EP2207534B1 (en) 2014-07-09
NZ584453A (en) 2012-06-29
ES2507079T3 (es) 2014-10-14
BRPI0817863A2 (pt) 2015-03-31
KR20100091956A (ko) 2010-08-19
AU2008306846A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
FR2883179B1 (fr) Comprime enrobe
MX2009007254A (es) Composiciones de tableta en tableta.
MX2010006823A (es) Metodos para el tratamiento de la gota.
WO2008070268A3 (en) Pharmaceutical compositions
MY147394A (en) Pyridonecarboxamides, crop protection agents containing the same, method for production and use thereof
WO2009129246A3 (en) Compositions and methods for preparing and using same
MY155529A (en) Overalls for cleanroom and the like
MX301786B (es) Fitasas variantes de buttiauxella sp. que tienen propiedades alteradas.
IL204844A (en) Coinolone analogues, pharmaceuticals containing them and their uses
PT2040755E (pt) Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
MX2010003591A (es) Capa protectora mecanica para formas de dosificacion solidas.
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
MY152388A (en) Composition and method for controlling plant diseases
EP2038304A4 (en) BST2 INHIBITORS
MX2008009830A (es) Efecto del inhibidor bst2.
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
NO20091386L (no) Fenyloksyanilinderivater
PL1999112T3 (pl) Podstawione 2-amino-4-fenylo-dihydrochinoliny, sposób ich wytwarzania, ich zastosowanie jako leku i lek je zawierający
ITBO20060233A1 (it) Apparecchiatura ausiliaria per trattamenti dentali.
UY31995A (es) Uso de idrabiotaparinux para disminuir la incidencia de hemorragias durante un tratamiento antitrombótico
PH12013500285A1 (en) Composition for preventing/controlling harmful arthropods and method for preventing/controlling harmful arthropods
WO2009003001A3 (en) Preparation of risedronate sodium hemi-pentahydrate
TW200833325A (en) Pharmaceutical composition comprising ascorbic acid

Legal Events

Date Code Title Description
FG Grant or registration